Does TAFASITAMAB Cause Pyrexia? 37 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Pyrexia have been filed in association with TAFASITAMAB (MONJUVI). This represents 2.7% of all adverse event reports for TAFASITAMAB.
37
Reports of Pyrexia with TAFASITAMAB
2.7%
of all TAFASITAMAB reports
10
Deaths
26
Hospitalizations
How Dangerous Is Pyrexia From TAFASITAMAB?
Of the 37 reports, 10 (27.0%) resulted in death, 26 (70.3%) required hospitalization, and 10 (27.0%) were considered life-threatening.
Is Pyrexia Listed in the Official Label?
Yes, Pyrexia is listed as a known adverse reaction in the official FDA drug label for TAFASITAMAB.
What Other Side Effects Does TAFASITAMAB Cause?
Disease progression (470)
Diffuse large b-cell lymphoma (346)
Off label use (203)
Death (146)
Neutropenia (99)
Covid-19 (96)
General physical health deterioration (75)
Pneumonia (66)
Febrile neutropenia (64)
Drug ineffective (62)
What Other Drugs Cause Pyrexia?
ADALIMUMAB (12,160)
METHOTREXATE (10,158)
RITUXIMAB (10,061)
PREDNISONE (8,141)
ETANERCEPT (7,626)
INFLIXIMAB (6,560)
ACETAMINOPHEN (6,414)
CYCLOPHOSPHAMIDE (6,126)
TOCILIZUMAB (5,529)
LENALIDOMIDE (5,496)
Which TAFASITAMAB Alternatives Have Lower Pyrexia Risk?
TAFASITAMAB vs TAFASITAMAB-CXIX
TAFASITAMAB vs TAFINLAR
TAFASITAMAB vs TAFLUPROST
TAFASITAMAB vs TAGRAXOFUSP-ERZS
TAFASITAMAB vs TAHOR